Stefanie Sarantopoulos, MD, PhD

Associate Professor of Medicine
Assistant Professor of Immunology
Member of the Duke Cancer Institute
Campus mail 152 Jones Bldg, Box 3961, Durham, NC 27710
Email address stefanie.sarantopoulos@duke.edu
In Their Words

Education and Training

  • Fellowship, Hematology/ Oncology, Dana Farber Cancer Institute, 2002 - 2005
  • Chief Resident, Internal Medicine, Boston University School of Medicine, 2001 - 2002
  • Resident, Internal Medicine, Boston University School of Medicine, 1999 - 2001
  • Intern, Internal Medicine, Boston University School of Medicine, 1998 - 1999
  • Ph.D., Boston University School of Medicine, 1998
  • M.D., Boston University, 1998

Publications

Chronic GVHD Consortium, Steven G. “Design and Patient Characteristics of the Chronic Graft-versus-Host Disease Response Measures Validation Study..” Biol Blood Marrow Transplant 24, no. 8 (August 2018): 1727–32. https://doi.org/10.1016/j.bbmt.2018.02.010.

PMID
29476954
Full Text

Wolff, D., H. Greinix, S. J. Lee, T. Gooley, S. Paczesny, S. Pavletic, F. Hakim, et al. “Biomarkers in chronic graft-versus-host disease: quo vadis?.” Bone Marrow Transplant 53, no. 7 (July 2018): 832–37. https://doi.org/10.1038/s41409-018-0092-x.

PMID
29367715
Full Text

Poe, Jonathan C., Wei Jia, Hsuan Su, Sarah Anand, Jeremy J. Rose, Prasanthi V. Tata, Amy N. Suthers, et al. “An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD..” Blood 130, no. 19 (November 9, 2017): 2131–45. https://doi.org/10.1182/blood-2017-05-782466.

PMID
28851699
Full Text

Anand, Sarah, Samantha Thomas, Kelly Corbet, Cristina Gasparetto, Gwynn D. Long, Richard Lopez, Ashley K. Morris, et al. “Adult Umbilical Cord Blood Transplantation Using Myeloablative Thiotepa, Total Body Irradiation, and Fludarabine Conditioning..” In Biol Blood Marrow Transplant, 23:1949–54, 2017. https://doi.org/10.1016/j.bbmt.2017.06.027.

PMID
28729147
Full Text

Poe, J., J. diPaolo, W. Jia, J. Y. Kim, H. Su, N. Reyes, A. M. Marcondes, et al. “Oral Syk inhibitor, Entospletinib (GS-9973), controls disease and enhances survival in a mouse model of chronic graft-versus host disease (cGVHD).” In Bone Marrow Transplantation, 52:S46–S46. NATURE PUBLISHING GROUP, 2017.

Scholars@Duke

Poe, J., J. diPaolo, W. Jia, J. Y. Kim, H. Su, N. Reyes, A. M. Marcondes, et al. “Oral Syk inhibitor, Entospletinib (GS-9973), controls disease and enhances survival in a mouse model of chronic graft-versus host disease (cGVHD).” In Bone Marrow Transplantation, 52:S46–S46. NATURE PUBLISHING GROUP, 2017.

Scholars@Duke

Anand, Sarah, Samantha Thomas, Terry Hyslop, Janet Adcock, Kelly Corbet, Cristina Gasparetto, Richard Lopez, et al. “Transplantation of Ex Vivo Expanded Umbilical Cord Blood (NiCord) Decreases Early Infection and Hospitalization..” Biol Blood Marrow Transplant 23, no. 7 (July 2017): 1151–57. https://doi.org/10.1016/j.bbmt.2017.04.001.

PMID
28392378
Full Text

Pages